104 related articles for article (PubMed ID: 9195133)
1. Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients.
Rizavi HS; Ren X; Zhang H; Bhaumik R; Pandey GN
Psychiatry Res; 2016 Jun; 240():314-320. PubMed ID: 27138824
[TBL] [Abstract][Full Text] [Related]
2. International nomenclature guidelines for the IL-1 family of cytokines and receptors.
Gaballa JM; Højen JF; De Graaf DM; Amo-Aparicio J; Marchetti C; Cavalli G; Dinarello A; Li S; Corbisiero MF; Tengesdal IW; Redzic JS; Azam T; Webber WS; Pankratz KA; May MJ; Cominelli F; Eisenmesser EZ; Kim S; Dinarello CA; Boraschi D
Nat Immunol; 2024 Apr; 25(4):581-582. PubMed ID: 38499798
[No Abstract] [Full Text] [Related]
3. Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play.
Chuliá-Peris L; Carreres-Rey C; Gabasa M; Alcaraz J; Carretero J; Pereda J
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805895
[TBL] [Abstract][Full Text] [Related]
4. Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone.
Chuang TY; Cheng AJ; Chen IT; Lan TY; Huang IH; Shiau CW; Hsu CL; Liu YW; Chang ZF; Tseng PH; Kuo JC
Oncotarget; 2017 Jul; 8(30):49735-49748. PubMed ID: 28537905
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9.
Appleby TC; Greenstein AE; Hung M; Liclican A; Velasquez M; Villaseñor AG; Wang R; Wong MH; Liu X; Papalia GA; Schultz BE; Sakowicz R; Smith V; Kwon HJ
J Biol Chem; 2017 Apr; 292(16):6810-6820. PubMed ID: 28235803
[TBL] [Abstract][Full Text] [Related]
6. ADAM8: a new therapeutic target for asthma.
Knolle MD; Owen CA
Expert Opin Ther Targets; 2009 May; 13(5):523-40. PubMed ID: 19397475
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium.
Lally F; Smith E; Filer A; Stone MA; Shaw JS; Nash GB; Buckley CD; Rainger GE
Arthritis Rheum; 2005 Nov; 52(11):3460-9. PubMed ID: 16255036
[TBL] [Abstract][Full Text] [Related]
8. Modulation of macrophage activity by proteolytic enzymes. Differential regulation of IL-6 and reactive oxygen intermediates (ROIs) synthesis as a possible homeostatic mechanism in the control of inflammation.
Bryniarski K; Maresz K; Szczepanik M; Ptak M; Ptak W
Inflammation; 2003 Dec; 27(6):333-40. PubMed ID: 14760941
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface.
Neznanov N; Kondratova A; Chumakov KM; Angres B; Zhumabayeva B; Agol VI; Gudkov AV
J Virol; 2001 Nov; 75(21):10409-20. PubMed ID: 11581409
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis.
Jacobsen SE; Jacobsen FW; Fahlman C; Rusten LS
Stem Cells; 1994; 12 Suppl 1():111-26; discussion 126-8. PubMed ID: 7535144
[TBL] [Abstract][Full Text] [Related]
11. Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins.
LaMarre J; Wollenberg GK; Gonias SL; Hayes MA
Lab Invest; 1991 Jul; 65(1):3-14. PubMed ID: 1712874
[TBL] [Abstract][Full Text] [Related]
12. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S
Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133
[TBL] [Abstract][Full Text] [Related]
13. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
Müllberg J; Durie FH; Otten-Evans C; Alderson MR; Rose-John S; Cosman D; Black RA; Mohler KM
J Immunol; 1995 Dec; 155(11):5198-205. PubMed ID: 7594530
[TBL] [Abstract][Full Text] [Related]
14. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.
Williams LM; Gibbons DL; Gearing A; Maini RN; Feldmann M; Brennan FM
J Clin Invest; 1996 Jun; 97(12):2833-41. PubMed ID: 8675695
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
